Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progression.

Molecular psychiatry·2026
Same author

[Links between type 2 diabetes and Parkinson's disease: pathophysiological and therapeutic evidence].

Medecine sciences : M/S·2026
Same author

Insulin resistance induced by pesticides is overcome by pancreatic islet adaptation in a mouse model of Parkinson's disease.

Molecular metabolism·2026
Same author

Human iPSC-derived airway models enable comparative analysis of SARS-CoV-2 infection in healthy and COPD bronchial epithelium.

iScience·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

The Combined Expression Profiles of Epigenetic Biomarkers Reveal Heterogeneity in Normospermic Human Sperm Samples.

Genes·2025
Same journal

Addendum: In situ architecture of the human prohibitin complex.

Nature cell biology·2026
Same journal

Evolutionarily conserved short linear motifs drive actin filament binding.

Nature cell biology·2026
Same journal

CD44 restricts EGFR mobility to polarize cytoskeletal signalling modules driving bleb-based migration.

Nature cell biology·2026
Same journal

Author Correction: Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance.

Nature cell biology·2026
Same journal

An atlas of primate insular cortex reveals a signal-processing strategy in von Economo neurons.

Nature cell biology·2026
Same journal

Primate neurons with special signalling logic.

Nature cell biology·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

The CDK4-pRB-E2F1 pathway controls insulin secretion.

Jean-Sébastien Annicotte1, Emilie Blanchet, Carine Chavey

  • 1INSERM, U834, Montpellier, F-34298, France.

Nature Cell Biology
|July 15, 2009
PubMed
Summary
This summary is machine-generated.

The CDK4-pRB-E2F1 pathway regulates Kir6.2 expression, impacting glucose-induced insulin secretion and glucose homeostasis. This study reveals a novel link between cell proliferation and metabolism in beta cells.

More Related Videos

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors
09:23

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors

Published on: March 7, 2017

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Related Experiment Videos

Last Updated: Jun 21, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors
09:23

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors

Published on: March 7, 2017

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Area of Science:

  • Cell Biology
  • Metabolic Regulation
  • Endocrinology

Background:

  • The CDK4-pRB-E2F1 pathway is expressed in non-proliferating beta cells, suggesting roles beyond cell-cycle control.
  • The K(ATP) channel, a key component in insulin secretion, involves Kir6.2.

Purpose of the Study:

  • To investigate the role of the CDK4-pRB-E2F1 pathway in beta-cell function and glucose homeostasis.
  • To elucidate the regulatory mechanism of Kir6.2 expression by the CDK4-pRB-E2F1 pathway.

Main Methods:

  • Chromatin immunoprecipitation analysis in tissues.
  • Inhibition of CDK4 and genetic inactivation of E2F1 in mice.
  • Rescue experiments in E2f1(-/-) beta cells.
  • Glucose stimulation and insulin pathway analysis.

Main Results:

  • E2F1 directly regulates Kir6.2 expression at the promoter level.
  • Inhibition of CDK4 or E2F1 inactivation decreased Kir6.2 expression, impaired insulin secretion, and caused glucose intolerance.
  • Restoring Kir6.2 expression rescued insulin secretion in E2f1(-/-) beta cells.
  • Glucose activates CDK4 via the insulin pathway, leading to E2F1 activation and increased Kir6.2 expression.

Conclusions:

  • The CDK4-pRB-E2F1 pathway is a critical regulator of Kir6.2 expression and glucose-induced insulin secretion.
  • This pathway plays a significant role in maintaining glucose homeostasis.
  • A novel connection between cell proliferation regulators and metabolic function in beta cells is established.